Search

Teva Pharmaceutical Industries Ltd.

Open

SectorGezondheidszorg

36.43 -3.09

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

36.29

Max

38.01

Belangrijke statistieken

By Trading Economics

Inkomsten

-944M

-575M

Verkoop

161M

4.1B

K/W

Sectorgemiddelde

62.593

57.366

EPS

0.64

Winstmarge

-13.882

Werknemers

31,173

EBITDA

-896M

-19M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+10.31% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

6.8B

43B

Vorige openingsprijs

39.52

Vorige sluitingsprijs

36.43

Nieuwssentiment

By Acuity

47%

53%

138 / 340 Rangschikking in Healthcare

Teva Pharmaceutical Industries Ltd. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 aug 2026, 23:56 UTC

Correlated Moves
News

Royal Gold shares are higher in after-market trading following CEO Bill Heissenbuttel's upcoming presentation at the Jefferies Global Industrials Conference on September 10.

27 aug 2026, 23:56 UTC

Correlated Moves
News

Diamondback Energy has risen in after-market hours following its joint venture for the Solitude Pipeline System, with analysts estimating a fair value of $232.17.

27 aug 2026, 23:51 UTC

News

Carlyle Group reported second-quarter revenue exceeding analyst expectations. In after-market trading, shares are advancing, reflecting a solid performance backdrop.

27 aug 2026, 23:51 UTC

Correlated Moves
News

The USD/HUF is trading higher, reflecting gains since Wednesday. A decline in initial jobless claims suggests strength in the U.S. economy.

27 aug 2026, 23:31 UTC

News

NAPCO Security Technologies Inc shares are lower in after-market hours, following broader market declines despite a 10% revenue increase in the fiscal fourth quarter.

27 aug 2026, 23:26 UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, amid a decline in the US 10Y Treasury Bond Index and investor sentiment shifts.

27 aug 2026, 23:11 UTC

News

Shares of Regenxbio are higher in after-market trading following a $949.4K insider purchase by director Gregor Ciongoli of 102.6K shares.

27 aug 2026, 23:06 UTC

Social Media
News

BioNTech SE's COVID-19 vaccine COMIRNATY® XFG receives FDA approval for adults 65 and older. Shares are trading higher in after-market hours.

27 aug 2026, 23:06 UTC

News

Shoals Technologies Group Inc shares declined in after-market trading despite winning a patent case against Voltage, LLC, with a jury awarding over $96 million.

27 aug 2026, 23:02 UTC

News

Permian Resources Corp shares are higher in after-market hours, boosted by Citigroup's outlook on the Permian Basin becoming the top U.S. natural gas producer.

27 aug 2026, 23:02 UTC

News

PDD Holdings reported second-quarter revenue of RMB112.4 billion, missing estimates. Shares are roughly flat in after-market trading amid rising operating expenses.

27 aug 2026, 23:02 UTC

Correlated Moves
News

Coinbase Global Inc. announced a token-backed mortgage product with Better Mortgage, boosting shares modestly higher in after-market trading.

27 aug 2026, 23:02 UTC

Social Media
News

Salesforce Inc. remains roughly flat in after-market hours amid discussions on short-selling dynamics and positive user experiences with its CRM system.

27 aug 2026, 23:02 UTC

News

Revolution Medicines Inc shares are higher in after-market trading following FDA approval of RASONQUE for metastatic pancreatic cancer, discussed during an August 26 conference call.

27 aug 2026, 23:02 UTC

News

Main Street Capital plans a supplemental dividend for December 2026, continuing its $0.30-per-share quarterly distribution. Shares are trading higher in after-market hours.

27 aug 2026, 23:02 UTC

Social Media
News

CrowdStrike Holdings Inc shares are lower in after-market hours, reflecting broader market declines despite recent strong earnings and positive revenue outlook.

27 aug 2026, 23:02 UTC

News

SFL Corporation reported Q2 revenue of $200.77 million and net income of $33.79 million. Shares are higher in after-market trading following the announcement.

27 aug 2026, 23:02 UTC

Social Media
Event
News

Gap Inc. shares rise in after-market trading following Q2 earnings that beat EPS estimates and included an adjusted EPS guidance increase.

27 aug 2026, 23:02 UTC

Social Media
News

Ulta Beauty Inc. shares are lower in after-market trading despite reporting strong second-quarter earnings and raising fiscal year guidance for net sales growth.

27 aug 2026, 23:02 UTC

News

Constellation Brands names Alex Alvarez as chief supply chain officer for its beer division. Shares are higher in after-market trading following initial dips.

27 aug 2026, 23:02 UTC

News

Rivian Automotive shares fell in after-market trading after CFO Claire McDonough announced her departure for GE Vernova, effective October 30.

27 aug 2026, 23:02 UTC

Event
Social Media
News

Affirm Holdings shares rise in after-market hours following a record fiscal fourth-quarter profit and revenue of $1.17 billion, exceeding estimates.

27 aug 2026, 23:02 UTC

Social Media
News

Pfizer and BioNTech received FDA approval for their XFG-adapted COVID-19 vaccine, COMIRNATY XFG, boosting shares in after-market trading.

27 aug 2026, 23:02 UTC

Social Media
News

Marvell Technology reported Q2 revenue of $2.74 billion, exceeding estimates, but shares are trading lower in after-market hours following the results.

27 aug 2026, 23:02 UTC

News
Correlated Moves

USD/PLN is gaining modestly today, influenced by initial jobless claims falling to 203,000, indicating ongoing strength in the labor market.

27 aug 2026, 23:02 UTC

Correlated Moves
Social Media
News

NVIDIA pauses revenue-sharing deals with AI cloud firms amid antitrust concerns, contributing to a modest decline in shares during after-market hours.

27 aug 2026, 23:02 UTC

Social Media
News

Veeva Systems Inc shares are lower in after-market trading, reflecting a broader market downturn despite earlier gains. The stock remains strong relative to its 20-day moving average.

27 aug 2026, 23:02 UTC

News

Bilibili Inc shares declined during after-market hours despite reporting strong growth in daily active users and advertising revenue. The stock remains below its 20-day moving average.

27 aug 2026, 23:01 UTC

News

Otis Worldwide Corp shares are lower in after-market trading, despite securing a significant contract for modernization at Tianjin 117 Tower in China.

27 aug 2026, 23:01 UTC

News
Correlated Moves

Intuit Inc. shares are lower in after-market trading following a downgrade by BofA Securities, which cut its fiscal 2027 revenue estimate to $23.4 billion.

Peer Vergelijking

Prijswijziging

Teva Pharmaceutical Industries Ltd. Prognose

Koersdoel

By TipRanks

10.31% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 41.5 USD  10.31%

Hoogste 44 USD

Laagste 40 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Teva Pharmaceutical Industries Ltd. - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Sentiment

By Acuity

138 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
help-icon Live chat